A Study of REGN5093 in Adult Patients With Mesenchymal Epithelial Transition Factor (MET)-Altered Advanced Non-Small Cell Lung Cancer
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
M.D. Anderson Cancer Center
Frontier Medicines Corporation
PMV Pharmaceuticals, Inc
Mayo Clinic
Verastem, Inc.
M.D. Anderson Cancer Center
Avenzo Therapeutics, Inc.
Aulos Bioscience, Inc.
Essen Biotech
Essen Biotech
Incyte Corporation
Memorial Sloan Kettering Cancer Center
DualityBio Inc.
Kidney Cancer Research Bureau
Second Life Therapeutics
Onchilles Pharma Inc
Ocellaris Pharma, Inc.
Pfizer
VM Oncology, LLC
Takeda
Liaoning Medical Diagnosis and Treatment Technology Research and Development Co., Ltd.
AstraZeneca
Transgene
Revolution Medicines, Inc.
Deciphera Pharmaceuticals, LLC
Memorial Sloan Kettering Cancer Center
Hadassah Medical Organization
7 Hills Pharma, LLC
GI Innovation, Inc.
Immuneering Corporation
Incyte Corporation
Incyte Corporation
Yuhan Corporation
NuCana plc
Hutchmed
NextCure, Inc.
Phanes Therapeutics
OncoResponse, Inc.
Deciphera Pharmaceuticals, LLC
NextCure, Inc.
Salubris Biotherapeutics Inc
NantCell, Inc.
Shanghai Chest Hospital
NantCell, Inc.
Turning Point Therapeutics, Inc.
Icahn School of Medicine at Mount Sinai
NextCure, Inc.
Augusta University
AstraZeneca